Length of activity: 30 minutes Professors Martin Savage and Stefano Cianfarani provide key clinical insights into the diagnosis and treatment of SPIGFD including data presented at the European Society for Paediatric Endocrinology (ESPE) Meeting 2018.
THIS CONTENT IS AVAILABLE FOR FREE TO REGISTERED USERS You are not currently logged in. LOGIN or REGISTER to access this content
LOGIN or REGISTER to access this content
Immediate, and unrestricted free access to all resources
Earn AMA PRA Category 1 Credits™ for completing accredited activities
Bi-weekly scientific newsletters highlighting the latest emerging data and industry news
Access to your personalised learning profile and CME record.
Watch a series of internationally renowned clinical specialists discuss the clinical landscape for severe primary IGF-1 deficiency (SPIGFD), including data from the European Society for Paediatric Endocrinology (ESPE) 2018 Congress in Athens, Greece, 27–29 September 2018.
The potential implications of these data for optimizing clinical outcomes for patients with SPIGFD are explored from both global and regional perspectives.
The information in this activity is intended for European endocrinologists, nurses, and other healthcare professionals involved in the treatment of patients with short stature.
After watching these touchCONGRESS Expert Interviews, you should be better prepared to:
Share your increased awareness and understanding of SPIGFD
Contribute to the optimization of diagnosis in paediatric growth hormone insensitivity syndromes
Demonstrate increased familiarity and confidence with early treatment of SPIGFD
Drive improved patient outcomes through sharing of best practice.
Please feedback on this touchCONGRESS Expert Interviews on the following: (scale 1-5, 1 strongly disagree; 5 strongly agree).